+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Diuretics Drugs Market - Global Forecast to 2030- Product Image
Diuretics Drugs Market - Global Forecast to 2030- Product Image
New

Diuretics Drugs Market - Global Forecast to 2030

  • PDF Icon

    Report

  • 198 Pages
  • May 2025
  • Region: Global, United States
  • 360iResearch™
  • ID: 6084069
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Diuretics Drugs Market grew from USD 1.29 billion in 2024 to USD 1.41 billion in 2025. It is expected to continue growing at a CAGR of 8.57%, reaching USD 2.12 billion by 2030.

In an era defined by an aging population and escalating incidence of cardiovascular, renal, and metabolic disorders, diuretic therapies have emerged as foundational elements of modern healthcare. These agents, commonly known as water pills, facilitate the excretion of excess fluid and electrolytes, thereby alleviating hypertension, edema, heart failure, and glaucoma. As global healthcare systems grapple with increasing cost pressures and the imperative to optimize patient outcomes, diuretics offer a cost-effective, proven intervention that supports chronic disease management.

Advancements in pharmacological research have expanded the range of diuretic subclasses-from loop diuretics and thiazides to potassium-sparing and osmotic variants-enabling clinicians to customize regimens for diverse patient profiles. Concurrently, novel delivery platforms and fixed-dose combinations have improved adherence and therapeutic efficacy. Against a backdrop of shifting regulatory frameworks, evolving reimbursement models, and complex global supply chains, stakeholders must navigate both opportunities and challenges to capture value in this dynamic segment.

This executive summary distills the key market drivers, emerging trends, and strategic imperatives shaping the diuretic landscape. It provides decision-makers with actionable insights into transformative shifts, the impact of recent tariffs, granular segmentation analysis, regional dynamics, competitive benchmarks, and practical recommendations for sustained growth and resilience.

Transformative Shifts Redefining the Diuretics Sector

Over the past five years, the diuretic market has witnessed transformative shifts driven by innovation, digital integration, and patient-centric care models. The rise of fixed-dose combinations, particularly thiazide-loop and thiazide-potassium-sparing formulations, reflects a broader trend toward simplification of regimens and enhanced compliance. Meanwhile, precision medicine initiatives have spurred interest in biomarkers and genetic profiling, enabling clinicians to tailor diuretic selection and dosing to individual patient physiology, thereby improving therapeutic outcomes and minimizing adverse events.

Digital health platforms and remote monitoring tools are reshaping disease management by providing real-time data on patient adherence, electrolyte balance, and fluid status. These insights allow proactive dose adjustments and reduce hospital readmissions for heart failure or edema. At the same time, regulatory authorities in key markets have accelerated approvals for novel diuretic entities and delivery systems, expediting time to market and fostering competitive differentiation.

Collaborations between pharmaceutical companies and technology providers are unlocking new business models, such as subscription-based access and value-based contracting, which reward improved patient outcomes over volume of sales. As the landscape evolves, manufacturers and payers alike must embrace these shifts to drive sustainable growth and meet the demands of an increasingly empowered patient population.

Analyzing the 2025 U.S. Tariff Impact on Diuretic Supply Chains

In 2025, the cumulative impact of new United States tariffs on pharmaceutical ingredients and finished products has reverberated across the diuretic supply chain. Tariffs imposed on key raw materials, including API precursors imported from major producers, have elevated production costs for loop diuretics, thiazides, and carbonic anhydrase inhibitors. These cost pressures have, in many cases, been passed on to wholesalers and pharmacies, prompting pricing adjustments that may affect reimbursement dynamics.

Manufacturers have responded by diversifying sourcing strategies, forging partnerships with domestic and non-tariff-impacted suppliers to mitigate exposure. Several key players have also accelerated investments in local API manufacturing facilities to secure supply continuity and control expense volatility. At the same time, strategic inventory management and contract renegotiations with distributors have become essential tactics for preserving margin integrity.

Despite short-term cost escalation, the tariff landscape has catalyzed long-term resilience initiatives, including reshoring efforts and supply chain digitalization. These measures have improved transparency, reduced lead times, and strengthened risk mitigation, ensuring that diuretic availability and affordability remain at the forefront of patient care.

Comprehensive Segmentation Insights Shaping Portfolio Strategy

A nuanced segmentation approach reveals the diversity and complexity of the diuretic market. By drug class, the landscape encompasses carbonic anhydrase inhibitors that manage intraocular pressure, loop diuretics renowned for potent natriuretic effects, osmotic diuretics suited to intracranial pressure scenarios, potassium-sparing agents that protect electrolyte balance, and thiazide diuretics favored in hypertension management. Route of administration further segments the market into oral forms-capsules and tablets dominating chronic care-parenteral injections for acute settings, and topical formulations tailored to ophthalmic applications.

Formulation insights highlight the growing share of fixed-dose combinations, notably thiazide-loop and thiazide-potassium-sparing blends, which simplify regimens and enhance adherence compared to single-entity products. Application segmentation spans chronic kidney disease management, edema control, glaucoma interventions, heart failure stabilization, and hypertension regulation. Patient demographics-adults, geriatric cohorts, and pediatric populations-exhibit distinct utilization patterns and dosing considerations, while mechanisms of action such as pH alteration, sodium and chloride reabsorption inhibition, and Loop of Henle modification drive efficacy differentials.

Distribution channels range from clinic overviews and hospital pharmacies to online and retail outlets, reflecting the omnichannel access strategies embraced by manufacturers. End-user settings include outpatient clinics, homecare environments, and inpatient hospitals. Packaging preferences-blister packs, bottles, pre-filled syringes-align with compliance imperatives. Finally, therapeutic indications cross cardiovascular, hepatic, and renal disorders, underscoring diuretics’ broad clinical relevance.

Key Regional Dynamics Steering Market Expansion

Regional analysis underscores distinct growth trajectories and market dynamics across the Americas, Europe, Middle East & Africa (EMEA), and Asia-Pacific. In the Americas, established healthcare infrastructure and favorable reimbursement frameworks have supported robust adoption of advanced diuretic formulations and combination therapies. North America, in particular, benefits from ongoing guideline updates that prioritize early intervention in hypertension and heart failure.

In the EMEA region, diversity in regulatory regimes and market access pathways presents both opportunities and complexities. Western European markets exhibit high penetration of branded combination diuretics, while emerging economies in the Middle East and Africa are experiencing rising demand driven by expanding primary care networks and improved diagnostic capabilities.

Asia-Pacific remains a high-growth frontier due to large patient populations confronting hypertension and renal diseases. Governments across China, India, and Southeast Asia are strengthening public health initiatives, enhancing screening programs, and expanding drug coverage, thereby fueling demand for cost-effective diuretic therapies. Additionally, incentivization schemes for local manufacturing are encouraging multinational players to invest in regional production hubs, ensuring supply resilience and price competitiveness.

Strategic Profiles of Leading Diuretic Manufacturers

Competitive analysis reveals a landscape shaped by both multinational powerhouses and agile regional players. AbbVie Inc. leverages its global R&D capabilities to advance novel diuretic compounds and fixed-dose combinations, while Amneal Pharmaceuticals LLC focuses on cost-effective generics that drive volume growth. Centaur Pharmaceuticals Pvt Ltd has carved a niche in emerging markets through value-oriented formulations, whereas Hikma Pharmaceuticals Inc. emphasizes strategic partnerships to enhance its branded and generic portfolios.

Merck & Co., Inc. continues to invest in cardiovascular research, positioning its diuretic offerings within broader heart failure management programs. Novartis International AG’s integrated platform of prescription diuretics and digital adherence tools enhances patient engagement and clinical outcomes. Perrigo Pharmaceuticals Company capitalizes on over-the-counter diuretic options to reach self-care segments, while Sanofi S.A. balances innovative pipeline projects with legacy brands to address both acute and chronic indications. Zydus Lifesciences Limited remains a prominent supplier of affordable generics and fixed-dose combinations, particularly in high-density markets across Asia and Latin America.

Actionable Recommendations for Industry Executives

Industry leaders should prioritize portfolio diversification by accelerating the development of fixed-dose combinations and novel delivery platforms that improve adherence and patient convenience. Strengthening supply chain resilience through multi-source procurement strategies and localized manufacturing will mitigate tariff disruptions and ensure cost predictability. Embracing digital health ecosystems-integrating remote monitoring, telemedicine, and patient engagement apps-can unlock new service-based revenue streams and differentiate offerings in a crowded market.

Collaborative partnerships with payers and healthcare providers are essential for designing value-based contracts that align pricing with real-world outcomes. Expanding market access in emerging regions requires targeted investments in local clinical studies, regulatory affairs, and distribution networks. In parallel, advanced analytics and AI-driven insights should inform dynamic demand forecasting and personalized marketing campaigns, optimizing resource allocation and accelerating time to revenue.

Finally, a proactive approach to regulatory intelligence-anticipating guideline revisions, compliance requirements, and tariff changes-will enable organizations to navigate complexity and capture new growth pockets effectively.

Conclusion: Navigating Opportunities in the Diuretic Arena

The diuretic market stands at the intersection of clinical necessity and commercial opportunity. As patient populations grow and comorbidities become more complex, diuretics will remain integral to treatment paradigms across cardiovascular, renal, and metabolic disorders. Ongoing innovation in formulations, delivery mechanisms, and digital health integrations will drive differentiation, while portfolio optimization and strategic alliances will underpin competitive advantage.

Amid evolving tariff landscapes and regulatory reforms, companies that invest in resilient supply chains, localized manufacturing, and data-driven decision-making will be best positioned for sustainable growth. A clear focus on patient centricity-delivering therapies that balance efficacy, safety, and convenience-must guide R&D and commercialization strategies.

By aligning organizational capabilities with market trends and regional nuances, stakeholders can harness the full potential of the diuretic segment, delivering improved patient outcomes and robust financial returns.

Market Segmentation & Coverage

This research report categorizes the Diuretics Drugs Market to forecast the revenues and analyze trends in each of the following sub-segmentations:

  • Carbonic Anhydrase Inhibitors
  • Loop Diuretics
  • Osmotic Diuretics
  • Potassium-sparing Diuretics
  • Thiazide Diuretics
  • Oral Forms
    • Capsules
    • Tablets
  • Parenteral Forms
  • Topical Forms
  • Fixed-Dose Combinations
    • Thiazide with Loop Diuretics
    • Thiazide with Potassium-sparing
  • Single-Entity Products
  • Chronic Kidney Disease
  • Edema
  • Glaucoma
  • Heart Failure
  • Hypertension
  • Adult
  • Geriatric
  • Pediatric
  • Alteration of pH Balance
  • Inhibition of Sodium and Chloride Reabsorption
  • Modification at Loop of Henle
  • Clinic Overview
  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies
  • Clinics
  • Homecare Settings
  • Hospitals
  • Blister Packs
  • Bottles
  • Pre-filled Syringes
  • Cardiovascular Diseases
  • Liver Disorders
  • Renal Disorders

This research report categorizes the Diuretics Drugs Market to forecast the revenues and analyze trends in each of the following sub-regions:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

This research report categorizes the Diuretics Drugs Market to delves into recent significant developments and analyze trends in each of the following companies:

  • AbbVie Inc.
  • Amneal Pharmaceuticals LLC
  • Centaur Pharmaceuticals Pvt Ltd
  • Hikma Pharmaceuticals Inc.
  • Merck & Co., Inc.
  • Novartis International AG
  • Perrigo Pharmaceuticals Company
  • Sanofi S.A.
  • Zydus Lifesciences Limited

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Diuretics Drugs Market, by Drug Class
8.1. Introduction
8.2. Carbonic Anhydrase Inhibitors
8.3. Loop Diuretics
8.4. Osmotic Diuretics
8.5. Potassium-sparing Diuretics
8.6. Thiazide Diuretics
9. Diuretics Drugs Market, by Route of Administration
9.1. Introduction
9.2. Oral Forms
9.2.1. Capsules
9.2.2. Tablets
9.3. Parenteral Forms
9.4. Topical Forms
10. Diuretics Drugs Market, by Formulation
10.1. Introduction
10.2. Fixed-Dose Combinations
10.2.1. Thiazide with Loop Diuretics
10.2.2. Thiazide with Potassium-sparing
10.3. Single-Entity Products
11. Diuretics Drugs Market, by Application
11.1. Introduction
11.2. Chronic Kidney Disease
11.3. Edema
11.4. Glaucoma
11.5. Heart Failure
11.6. Hypertension
12. Diuretics Drugs Market, by Patient Type
12.1. Introduction
12.2. Adult
12.3. Geriatric
12.4. Pediatric
13. Diuretics Drugs Market, by Mechanism of Action
13.1. Introduction
13.2. Alteration of pH Balance
13.3. Inhibition of Sodium and Chloride Reabsorption
13.4. Modification at Loop of Henle
14. Diuretics Drugs Market, by Distribution Channel
14.1. Introduction
14.2. Clinic Overview
14.3. Hospital Pharmacies
14.4. Online Pharmacies
14.5. Retail Pharmacies
15. Diuretics Drugs Market, by End-user
15.1. Introduction
15.2. Clinics
15.3. Homecare Settings
15.4. Hospitals
16. Diuretics Drugs Market, by Packaging Type
16.1. Introduction
16.2. Blister Packs
16.3. Bottles
16.4. Pre-filled Syringes
17. Diuretics Drugs Market, by Therapeutic Indications
17.1. Introduction
17.2. Cardiovascular Diseases
17.3. Liver Disorders
17.4. Renal Disorders
18. Americas Diuretics Drugs Market
18.1. Introduction
18.2. Argentina
18.3. Brazil
18.4. Canada
18.5. Mexico
18.6. United States
19. Asia-Pacific Diuretics Drugs Market
19.1. Introduction
19.2. Australia
19.3. China
19.4. India
19.5. Indonesia
19.6. Japan
19.7. Malaysia
19.8. Philippines
19.9. Singapore
19.10. South Korea
19.11. Taiwan
19.12. Thailand
19.13. Vietnam
20. Europe, Middle East & Africa Diuretics Drugs Market
20.1. Introduction
20.2. Denmark
20.3. Egypt
20.4. Finland
20.5. France
20.6. Germany
20.7. Israel
20.8. Italy
20.9. Netherlands
20.10. Nigeria
20.11. Norway
20.12. Poland
20.13. Qatar
20.14. Russia
20.15. Saudi Arabia
20.16. South Africa
20.17. Spain
20.18. Sweden
20.19. Switzerland
20.20. Turkey
20.21. United Arab Emirates
20.22. United Kingdom
21. Competitive Landscape
21.1. Market Share Analysis, 2024
21.2. FPNV Positioning Matrix, 2024
21.3. Competitive Analysis
21.3.1. AbbVie Inc.
21.3.2. Amneal Pharmaceuticals LLC
21.3.3. Centaur Pharmaceuticals Pvt Ltd
21.3.4. Hikma Pharmaceuticals Inc.
21.3.5. Merck & Co., Inc.
21.3.6. Novartis International AG
21.3.7. Perrigo Pharmaceuticals Company
21.3.8. Sanofi S.A.
21.3.9. Zydus Lifesciences Limited
22. ResearchAI
23. ResearchStatistics
24. ResearchContacts
25. ResearchArticles
26. Appendix
List of Figures
FIGURE 1. DIURETICS DRUGS MARKET MULTI-CURRENCY
FIGURE 2. DIURETICS DRUGS MARKET MULTI-LANGUAGE
FIGURE 3. DIURETICS DRUGS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL DIURETICS DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL DIURETICS DRUGS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL DIURETICS DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL DIURETICS DRUGS MARKET SIZE, BY DRUG CLASS, 2024 VS 2030 (%)
FIGURE 8. GLOBAL DIURETICS DRUGS MARKET SIZE, BY DRUG CLASS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL DIURETICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL DIURETICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL DIURETICS DRUGS MARKET SIZE, BY FORMULATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL DIURETICS DRUGS MARKET SIZE, BY FORMULATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL DIURETICS DRUGS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL DIURETICS DRUGS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL DIURETICS DRUGS MARKET SIZE, BY PATIENT TYPE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL DIURETICS DRUGS MARKET SIZE, BY PATIENT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL DIURETICS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2024 VS 2030 (%)
FIGURE 18. GLOBAL DIURETICS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. GLOBAL DIURETICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 20. GLOBAL DIURETICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. GLOBAL DIURETICS DRUGS MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
FIGURE 22. GLOBAL DIURETICS DRUGS MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. GLOBAL DIURETICS DRUGS MARKET SIZE, BY PACKAGING TYPE, 2024 VS 2030 (%)
FIGURE 24. GLOBAL DIURETICS DRUGS MARKET SIZE, BY PACKAGING TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. GLOBAL DIURETICS DRUGS MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2024 VS 2030 (%)
FIGURE 26. GLOBAL DIURETICS DRUGS MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. AMERICAS DIURETICS DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 28. AMERICAS DIURETICS DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 29. UNITED STATES DIURETICS DRUGS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 30. UNITED STATES DIURETICS DRUGS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 31. ASIA-PACIFIC DIURETICS DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 32. ASIA-PACIFIC DIURETICS DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 33. EUROPE, MIDDLE EAST & AFRICA DIURETICS DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 34. EUROPE, MIDDLE EAST & AFRICA DIURETICS DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 35. DIURETICS DRUGS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 36. DIURETICS DRUGS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. DIURETICS DRUGS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL DIURETICS DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL DIURETICS DRUGS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL DIURETICS DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL DIURETICS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL DIURETICS DRUGS MARKET SIZE, BY CARBONIC ANHYDRASE INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL DIURETICS DRUGS MARKET SIZE, BY LOOP DIURETICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL DIURETICS DRUGS MARKET SIZE, BY OSMOTIC DIURETICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL DIURETICS DRUGS MARKET SIZE, BY POTASSIUM-SPARING DIURETICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL DIURETICS DRUGS MARKET SIZE, BY THIAZIDE DIURETICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL DIURETICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL DIURETICS DRUGS MARKET SIZE, BY ORAL FORMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL DIURETICS DRUGS MARKET SIZE, BY CAPSULES, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL DIURETICS DRUGS MARKET SIZE, BY TABLETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL DIURETICS DRUGS MARKET SIZE, BY ORAL FORMS, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL DIURETICS DRUGS MARKET SIZE, BY PARENTERAL FORMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL DIURETICS DRUGS MARKET SIZE, BY TOPICAL FORMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL DIURETICS DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL DIURETICS DRUGS MARKET SIZE, BY FIXED-DOSE COMBINATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL DIURETICS DRUGS MARKET SIZE, BY THIAZIDE WITH LOOP DIURETICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL DIURETICS DRUGS MARKET SIZE, BY THIAZIDE WITH POTASSIUM-SPARING, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL DIURETICS DRUGS MARKET SIZE, BY FIXED-DOSE COMBINATIONS, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL DIURETICS DRUGS MARKET SIZE, BY SINGLE-ENTITY PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL DIURETICS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL DIURETICS DRUGS MARKET SIZE, BY CHRONIC KIDNEY DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL DIURETICS DRUGS MARKET SIZE, BY EDEMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL DIURETICS DRUGS MARKET SIZE, BY GLAUCOMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL DIURETICS DRUGS MARKET SIZE, BY HEART FAILURE, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL DIURETICS DRUGS MARKET SIZE, BY HYPERTENSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL DIURETICS DRUGS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL DIURETICS DRUGS MARKET SIZE, BY ADULT, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL DIURETICS DRUGS MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL DIURETICS DRUGS MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL DIURETICS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL DIURETICS DRUGS MARKET SIZE, BY ALTERATION OF PH BALANCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL DIURETICS DRUGS MARKET SIZE, BY INHIBITION OF SODIUM AND CHLORIDE REABSORPTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL DIURETICS DRUGS MARKET SIZE, BY MODIFICATION AT LOOP OF HENLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL DIURETICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL DIURETICS DRUGS MARKET SIZE, BY CLINIC OVERVIEW, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL DIURETICS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL DIURETICS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL DIURETICS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL DIURETICS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL DIURETICS DRUGS MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL DIURETICS DRUGS MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL DIURETICS DRUGS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL DIURETICS DRUGS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL DIURETICS DRUGS MARKET SIZE, BY BLISTER PACKS, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL DIURETICS DRUGS MARKET SIZE, BY BOTTLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL DIURETICS DRUGS MARKET SIZE, BY PRE-FILLED SYRINGES, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL DIURETICS DRUGS MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL DIURETICS DRUGS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL DIURETICS DRUGS MARKET SIZE, BY LIVER DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL DIURETICS DRUGS MARKET SIZE, BY RENAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS DIURETICS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS DIURETICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS DIURETICS DRUGS MARKET SIZE, BY ORAL FORMS, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS DIURETICS DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS DIURETICS DRUGS MARKET SIZE, BY FIXED-DOSE COMBINATIONS, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS DIURETICS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS DIURETICS DRUGS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS DIURETICS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS DIURETICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS DIURETICS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS DIURETICS DRUGS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS DIURETICS DRUGS MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS DIURETICS DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 69. ARGENTINA DIURETICS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 70. ARGENTINA DIURETICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 71. ARGENTINA DIURETICS DRUGS MARKET SIZE, BY ORAL FORMS, 2018-2030 (USD MILLION)
TABLE 72. ARGENTINA DIURETICS DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 73. ARGENTINA DIURETICS DRUGS MARKET SIZE, BY FIXED-DOSE COMBINATIONS, 2018-2030 (USD MILLION)
TABLE 74. ARGENTINA DIURETICS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 75. ARGENTINA DIURETICS DRUGS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 76. ARGENTINA DIURETICS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 77. ARGENTINA DIURETICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 78. ARGENTINA DIURETICS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 79. ARGENTINA DIURETICS DRUGS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 80. ARGENTINA DIURETICS DRUGS MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2030 (USD MILLION)
TABLE 81. BRAZIL DIURETICS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 82. BRAZIL DIURETICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 83. BRAZIL DIURETICS DRUGS MARKET SIZE, BY ORAL FORMS, 2018-2030 (USD MILLION)
TABLE 84. BRAZIL DIURETICS DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 85. BRAZIL DIURETICS DRUGS MARKET SIZE, BY FIXED-DOSE COMBINATIONS, 2018-2030 (USD MILLION)
TABLE 86. BRAZIL DIURETICS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 87. BRAZIL DIURETICS DRUGS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 88. BRAZIL DIURETICS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 89. BRAZIL DIURETICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 90. BRAZIL DIURETICS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 91. BRAZIL DIURETICS DRUGS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 92. BRAZIL DIURETICS DRUGS MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2030 (USD MILLION)
TABLE 93. CANADA DIURETICS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 94. CANADA DIURETICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 95. CANADA DIURETICS DRUGS MARKET SIZE, BY ORAL FORMS, 2018-2030 (USD MILLION)
TABLE 96. CANADA DIURETICS DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 97. CANADA DIURETICS DRUGS MARKET SIZE, BY FIXED-DOSE COMBINATIONS, 2018-2030 (USD MILLION)
TABLE 98. CANADA DIURETICS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 99. CANADA DIURETICS DRUGS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 100. CANADA DIURETICS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 101. CANADA DIURETICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 102. CANADA DIURETICS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 103. CANADA DIURETICS DRUGS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 104. CANADA DIURETICS DRUGS MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2030 (USD MILLION)
TABLE 105. MEXICO DIURETICS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 106. MEXICO DIURETICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 107. MEXICO DIURETICS DRUGS MARKET SIZE, BY ORAL FORMS, 2018-2030 (USD MILLION)
TABLE 108. MEXICO DIURETICS DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 109. MEXICO DIURETICS DRUGS MARKET SIZE, BY FIXED-DOSE COMBINATIONS, 2018-2030 (USD MILLION)
TABLE 110. MEXICO DIURETICS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 111. MEXICO DIURETICS DRUGS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 112. MEXICO DIURETICS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 113. MEXICO DIURETICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 114. MEXICO DIURETICS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 115. MEXICO DIURETICS DRUGS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 116. MEXICO DIURETICS DRUGS MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2030 (USD MILLION)
TABLE 117. UNITED STATES DIURETICS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 118. UNITED STATES DIURETICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 119. UNITED STATES DIURETICS DRUGS MARKET SIZE, BY ORAL FORMS, 2018-2030 (USD MILLION)
TABLE 120. UNITED STATES DIURETICS DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 121. UNITED STATES DIURETICS DRUGS MARKET SIZE, BY FIXED-DOSE COMBINATIONS, 2018-2030 (USD MILLION)
TABLE 122. UNITED STATES DIURETICS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 123. UNITED STATES DIURETICS DRUGS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 124. UNITED STATES DIURETICS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 125. UNITED STATES DIURETICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 126. UNITED STATES DIURETICS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 127. UNITED STATES DIURETICS DRUGS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 128. UNITED STATES DIURETICS DRUGS MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2030 (USD MILLION)
TABLE 129. UNITED STATES DIURETICS DRUGS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 130. ASIA-PACIFIC DIURETICS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 131. ASIA-PACIFIC DIURETICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 132. ASIA-PACIFIC DIURETICS DRUGS MARKET SIZE, BY ORAL FORMS, 2018-2030 (USD MILLION)
TABLE 133. ASIA-PACIFIC DIURETICS DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 134. ASIA-PACIFIC DIURETICS DRUGS MARKET SIZE, BY FIXED-DOSE COMBINATIONS, 2018-2030 (USD MILLION)
TABLE 135. ASIA-PACIFIC DIURETICS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 136. ASIA-PACIFIC DIURETICS DRUGS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 137. ASIA-PACIFIC DIURETICS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 138. ASIA-PACIFIC DIURETICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 139. ASIA-PACIFIC DIURETICS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 140. ASIA-PACIFIC DIURETICS DRUGS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 141. ASIA-PACIFIC DIURETICS DRUGS MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2030 (USD MILLION)
TABLE 142. ASIA-PACIFIC DIURETICS DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 143. AUSTRALIA DIURETICS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 144. AUSTRALIA DIURETICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 145. AUSTRALIA DIURETICS DRUGS MARKET SIZE, BY ORAL FORMS, 2018-2030 (USD MILLION)
TABLE 146. AUSTRALIA DIURETICS DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 147. AUSTRALIA DIURETICS DRUGS MARKET SIZE, BY FIXED-DOSE COMBINATIONS, 2018-2030 (USD MILLION)
TABLE 148. AUSTRALIA DIURETICS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 149. AUSTRALIA DIURETICS DRUGS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 150. AUSTRALIA DIURETICS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 151. AUSTRALIA DIURETICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 152. AUSTRALIA DIURETICS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 153. AUSTRALIA DIURETICS DRUGS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 154. AUSTRALIA DIURETICS DRUGS MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2030 (USD MILLION)
TABLE 155. CHINA DIURETICS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 156. CHINA DIURETICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 157. CHINA DIURETICS DRUGS MARKET SIZE, BY ORAL FORMS, 2018-2030 (USD MILLION)
TABLE 158. CHINA DIURETICS DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 159. CHINA DIURETICS DRUGS MARKET SIZE, BY FIXED-DOSE COMBINATIONS, 2018-2030 (USD MILLION)
TABLE 160. CHINA DIURETICS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 161. CHINA DIURETICS DRUGS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 162. CHINA DIURETICS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 163. CHINA DIURETICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 164. CHINA DIURETICS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 165. CHINA DIURETICS DRUGS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 166. CHINA DIURETICS DRUGS MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2030 (USD MILLION)
TABLE 167. INDIA DIURETICS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 168. INDIA DIURETICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 169. INDIA DIURETICS DRUGS MARKET SIZE, BY ORAL FORMS, 2018-2030 (USD MILLION)
TABLE 170. INDIA DIURETICS DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 171. INDIA DIURETICS DRUGS MARKET SIZE, BY FIXED-DOSE COMBINATIONS, 2018-2030 (USD MILLION)
TABLE 172. INDIA DIURETICS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 173. INDIA DIURETICS DRUGS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 174. INDIA DIURETICS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 175. INDIA DIURETICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 176. INDIA DIURETICS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 177. INDIA DIURETICS DRUGS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 178. INDIA DIURETICS DRUGS MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2030 (USD MILLION)
TABLE 179. INDONESIA DIURETICS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 180. INDONESIA DIURETICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 181. INDONESIA DIURETICS DRUGS MARKET SIZE, BY ORAL FORMS, 2018-2030 (USD MILLION)
TABLE 182. INDONESIA DIURETICS DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 183. INDONESIA DIURETICS DRUGS MARKET SIZE, BY FIXED-DOSE COMBINATIONS, 2018-2030 (USD MILLION)
TABLE 184. INDONESIA DIURETICS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 185. INDONESIA DIURETICS DRUGS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 186. INDONESIA DIURETICS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 187. INDONESIA DIURETICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 188. INDONESIA DIURETICS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 189. INDONESIA DIURETICS DRUGS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 190. INDONESIA DIURETICS DRUGS MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2030 (USD MILLION)
TABLE 191. JAPAN DIURETICS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 192. JAPAN DIURETICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 193. JAPAN DIURETICS DRUGS MARKET SIZE, BY ORAL FORMS, 2018-2030 (USD MILLION)
TABLE 194. JAPAN DIURETICS DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 195. JAPAN DIURETICS DRUGS MARKET SIZE, BY FIXED-DOSE COMBINATIONS, 2018-2030 (USD MILLION)
TABLE 196. JAPAN DIURETICS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 197. JAPAN DIURETICS DRUGS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 198. JAPAN DIURETICS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 199. JAPAN DIURETICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 200. JAPAN DIURETICS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 201. JAPAN DIURETICS DRUGS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 202. JAPAN DIURETICS DRUGS MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2030 (USD MILLION)
TABLE 203. MALAYSIA DIURETICS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 204. MALAYSIA DIURETICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 205. MALAYSIA DIURETICS DRUGS MARKET SIZE, BY ORAL FORMS, 2018-2030 (USD MILLION)
TABLE 206. MALAYSIA DIURETICS DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 207. MALAYSIA DIURETICS DRUGS MARKET SIZE, BY FIXED-DOSE COMBINATIONS, 2018-2030 (USD MILLION)
TABLE 208. MALAYSIA DIURETICS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 209. MALAYSIA DIURETICS DRUGS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 210. MALAYSIA DIURETICS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 211. MALAYSIA DIURETICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 212. MALAYSIA DIURETICS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 213. MALAYSIA DIURETICS DRUGS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 214. MALAYSIA DIURETICS DRUGS MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2030 (USD MILLION)
TABLE 215. PHILIPPINES DIURETICS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 216. PHILIPPINES DIURETICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 217. PHILIPPINES DIURETICS DRUGS MARKET SIZE, BY ORAL FORMS, 2018-2030 (USD MILLION)
TABLE 218. PHILIPPINES DIURETICS DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 219. PHILIPPINES DIURETICS DRUGS MARKET SIZE, BY FIXED-DOSE COMBINATIONS, 2018-2030 (USD MILLION)
TABLE 220. PHILIPPINES DIURETICS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 221. PHILIPPINES DIURETICS DRUGS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 222. PHILIPPINES DIURETICS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 223. PHILIPPINES DIURETICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 224. PHILIPPINES DIURETICS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 225. PHILIPPINES DIURETICS DRUGS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 226. PHILIPPINES DIURETICS DRUGS MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2030 (USD MILLION)
TABLE 227. SINGAPORE DIURETICS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 228. SINGAPORE DIURETICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 229. SINGAPORE DIURETICS DRUGS MARKET SIZE, BY ORAL FORMS, 2018-2030 (USD MILLION)
TABLE 230. SINGAPORE DIURETICS DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 231. SINGAPORE DIURETICS DRUGS MARKET SIZE, BY FIXED-DOSE COMBINATIONS, 2018-2030 (USD MILLION)
TABLE 232. SINGAPORE DIURETICS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 233. SINGAPORE DIURETICS DRUGS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 234. SINGAPORE DIURETICS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 235. SINGAPORE DIURETICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 236. SINGAPORE DIURETICS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 237. SINGAPORE DIURETICS DRUGS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 238. SINGAPORE DIURETICS DRUGS MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2030 (USD MILLION)
TABLE 239. SOUTH KOREA DIURETICS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 240. SOUTH KOREA DIURETICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 241. SOUTH KOREA DIURETICS DRUGS MARKET SIZE, BY ORAL FORMS, 2018-2030 (USD MILLION)
TABLE 242. SOUTH KOREA DIURETICS DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 243. SOUTH KOREA DIURETICS DRUGS MARKET SIZE, BY FIXED-DOSE COMBINATIONS, 2018-2030 (USD MILLION)
TABLE 244. SOUTH KOREA DIURETICS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 245. SOUTH KOREA DIURETICS DRUGS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 246. SOUTH KOREA DIURETICS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 247. SOUTH KOREA DIURETICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 248. SOUTH KOREA DIURETICS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 249. SOUTH KOREA DIURETICS DRUGS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 250. SOUTH KOREA DIURETICS DRUGS MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2030 (USD MILLION)
TABLE 251. TAIWAN DIURETICS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 252. TAIWAN DIURETICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 253. TAIWAN DIURETICS DRUGS MARKET SIZE, BY ORAL FORMS, 2018-2030 (USD MILLION)
TABLE 254. TAIWAN DIURETICS DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 255. TAIWAN DIURETICS DRUGS MARKET SIZE, BY FIXED-DOSE COMBINATIONS, 2018-2030 (USD MILLION)
TABLE 256. TAIWAN DIURETICS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 257. TAIWAN DIURETICS DRUGS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 258. TAIWAN DIURETICS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 259. TAIWAN DIURETICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 260. TAIWAN DIURETICS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 261. TAIWAN DIURETICS DRUGS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 262. TAIWAN DIURETICS DRUGS MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2030 (USD MILLION)
TABLE 263. THAILAND DIURETICS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 264. THAILAND DIURETICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 265. THAILAND DIURETICS DRUGS MARKET SIZE, BY ORAL FORMS, 2018-2030 (USD MILLION)
TABLE 266. THAILAND DIURETICS DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 267. THAILAND DIURETICS DRUGS MARKET SIZE, BY FIXED-DOSE COMBINATIONS, 2018-2030 (USD MILLION)
TABLE 268. THAILAND DIURETICS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 269. THAILAND DIURETICS DRUGS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 270. THAILAND DIURETICS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 271. THAILAND DIURETICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 272. THAILAND DIURETICS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 273. THAILAND DIURETICS DRUGS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 274. THAILAND DIURETICS DRUGS MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2030 (USD MILLION)
TABLE 275. VIETNAM DIURETICS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 276. VIETNAM DIURETICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 277. VIETNAM DIURETICS DRUGS MARKET SIZE, BY ORAL FORMS, 2018-2030 (USD MILLION)
TABLE 278. VIETNAM DIURETICS DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 279. VIETNAM DIURETICS DRUGS MARKET SIZE, BY FIXED-DOSE COMBINATIONS, 2018-2030 (USD MILLION)
TABLE 280. VIETNAM DIURETICS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 281. VIETNAM DIURETICS DRUGS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 282. VIETNAM DIURETICS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 283. VIETNAM DIURETICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 284. VIETNAM DIURETICS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 285. VIETNAM DIURETICS DRUGS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 286. VIETNAM DIURETICS DRUGS MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2030 (USD MILLION)
TABLE 287. EUROPE, MIDDLE EAST & AFRICA DIURETICS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 288. EUROPE, MIDDLE EAST & AFRICA DIURETICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 289. EUROPE, MIDDLE EAST & AFRICA DIURETICS DRUGS MARKET SIZE, BY ORAL FORMS, 2018-2030 (USD MILLION)
TABLE 290. EUROPE, MIDDLE EAST & AFRICA DIURETICS DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 291. EUROPE, MIDDLE EAST & AFRICA DIURETICS DRUGS MARKET SIZE, BY FIXED-DOSE COMBINATIONS, 2018-2030 (USD MILLION)
TABLE 292. EUROPE, MIDDLE EAST & AFRICA DIURETICS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 293. EUROPE, MIDDLE EAST & AFRICA DIURETICS DRUGS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 294. EUROPE, MIDDLE EAST & AFRICA DIURETICS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 295. EUROPE, MIDDLE EAST & AFRICA DIURETICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 296. EUROPE, MIDDLE EAST & AFRICA DIURETICS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 297. EUROPE, MIDDLE EAST & AFRICA DIURETICS DRUGS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 298. EUROPE, MIDDLE EAST & AFRICA DIURETICS DRUGS MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2030 (USD MILLION)
TABLE 299. EUROPE, MIDDLE EAST & AFRICA DIURETICS DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 300. DENMARK DIURETICS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 301. DENMARK DIURETICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 302. DENMARK DIURETICS DRUGS MARKET SIZE, BY ORAL FORMS, 2018-2030 (USD MILLION)
TABLE 303. DENMARK DIURETICS DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 304. DENMARK DIURETICS DRUGS MARKET SIZE, BY FIXED-DOSE COMBINATIONS, 2018-2030 (USD MILLION)
TABLE 305. DENMARK DIURETICS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 306. DENMARK DIURETICS DRUGS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 307. DENMARK DIURETICS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 308. DENMARK DIURETICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 309. DENMARK DIURETICS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 310. DENMARK DIURETICS DRUGS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 311. DENMARK DIURETICS DRUGS MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2030 (USD MILLION)
TABLE 312. EGYPT DIURETICS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 313. EGYPT DIURETICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 314. EGYPT DIURETICS DRUGS MARKET SIZE, BY ORAL FORMS, 2018-2030 (USD MILLION)
TABLE 315. EGYPT DIURETICS DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 316. EGYPT DIURETICS DRUGS MARKET SIZE, BY FIXED-DOSE COMBINATIONS, 2018-2030 (USD MILLION)
TABLE 317. EGYPT DIURETICS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 318. EGYPT DIURETICS DRUGS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 319. EGYPT DIURETICS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 320. EGYPT DIURETICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 321. EGYPT DIURETICS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 322. EGYPT DIURETICS DRUGS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 323. EGYPT DIURETICS DRUGS MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2030 (USD MILLION)
TABLE 324. FINLAND DIURETICS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 325. FINLAND DIURETICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 326. FINLAND DIURETICS DRUGS MARKET SIZE, BY ORAL FORMS, 2018-2030 (USD MILLION)
TABLE 327. FINLAND DIURETICS DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 328. FINLAND DIURETICS DRUGS MARKET SIZE, BY FIXED-DOSE COMBINATIONS, 2018-2030 (USD MILLION)
TABLE 329. FINLAND DIURETICS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 330. FINLAND DIURETICS DRUGS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 331. FINLAND DIURETICS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 332. FINLAND DIURETICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 333. FINLAND DIURETICS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 334. FINLAND DIURETICS DRUGS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 335. FINLAND DIURETICS DRUGS MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2030 (USD MILLION)
TABLE 336. FRANCE DIURETICS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 337. FRANCE DIURETICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 338. FRANCE DIURETICS DRUGS MARKET SIZE, BY ORAL FORMS, 2018-2030 (USD MILLION)
TABLE 339. FRANCE DIURETICS DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 340. FRANCE DIURETICS DRUGS MARKET SIZE, BY FIXED-DOSE COMBINATIONS, 2018-2030 (USD MILLION)
TABLE 341. FRANCE DIURETICS DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 342. FRANCE DIURETICS DRUGS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 343. FRANCE DIURETICS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 344. FRANCE DIURETICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 345. FRANCE DIURETICS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 346. FRANCE DIURETICS DRUGS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 347. FRANCE DIURETICS DRUGS MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2030 (USD MILLION)
TABLE 348. GERMANY DIURETICS DRUGS MARKET SIZE, BY DRUG CLASS, 2018

Companies Mentioned

  • AbbVie Inc.
  • Amneal Pharmaceuticals LLC
  • Centaur Pharmaceuticals Pvt Ltd
  • Hikma Pharmaceuticals Inc.
  • Merck & Co., Inc.
  • Novartis International AG
  • Perrigo Pharmaceuticals Company
  • Sanofi S.A.
  • Zydus Lifesciences Limited

Methodology

Loading
LOADING...

Related Topics

Related Reports

Diuretics Drugs Market by Drug Type, Distribution Channel, Route of Administration, Applications - Global Forecast 2025-2030 - Product Image

Diuretics Drugs Market by Drug Type, Distribution Channel, Route of Administration, Applications - Global Forecast 2025-2030

  • Report
  • 199 Pages
  • Global
From
Diuretic Drugs - Global Strategic Business Report - Product Image

Diuretic Drugs - Global Strategic Business Report

  • Report
  • 372 Pages
  • Global
From
Diuretic Drugs Market 2024-2028 - Product Image

Diuretic Drugs Market 2024-2028

  • Report
  • 137 Pages
  • Global
From
Diuretics Market Report 2025 - Product Image

Diuretics Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Nocturia - Pipeline Insight, 2025 - Product Image

Nocturia - Pipeline Insight, 2025

  • Clinical Trials
  • 40 Pages
  • Global
From

About the Diuretic Agent Market

The Diuretic Agent market is a subset of the Urological Disorders Drugs market, which focuses on medications used to treat conditions related to the urinary system. Diuretics are used to reduce the amount of fluid in the body, and are commonly prescribed to treat high blood pressure, heart failure, and kidney disease. They work by increasing the amount of salt and water that is excreted in the urine. Diuretics can also be used to reduce swelling caused by certain medical conditions. Diuretics are available in a variety of forms, including tablets, capsules, and injectables. Commonly prescribed diuretics include furosemide, hydrochlorothiazide, and spironolactone. The Diuretic Agent market is highly competitive, with many companies offering a range of products. Some of the major players in the market include Pfizer, Merck, Novartis, Sanofi, and AstraZeneca. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.